Macrophage membrane-biomimetic ROS-responsive platinum nanozyme clusters for acute kidney injury treatment

Hanzhi Deng1, Ying Qu1, Bingyang Chu1

  • 1Department of Biotherapy and Department of Hematology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

Biomaterials
|January 11, 2025
PubMed

Insights

A novel biomimetic nano-system (MM-PtNCs) effectively treats acute kidney injury (AKI) by targeting inflammation and scavenging reactive oxygen species (ROS). This approach reduces kidney damage and prevents progression to chronic kidney disease.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Renal Physiology

Background:

  • Acute kidney injury (AKI) is a prevalent condition with no effective treatments, characterized by rapid loss of kidney function.
  • Oxidative stress and inflammation are key drivers in AKI development and progression.
  • Current therapeutic options for AKI are limited.

Purpose of the Study:

  • To develop and evaluate a novel biomimetic nano-system (MM-PtNCs) for alleviating AKI.
  • To investigate the potential of MM-PtNCs in modulating oxidative stress and inflammation in AKI.
  • To assess the efficacy of MM-PtNCs in preventing AKI progression to chronic kidney disease.

Main Methods:

  • Development of a macrophage membrane (MM)-coated nano-system encapsulating reactive oxygen species (ROS)-responsive platinum nanozyme clusters (PtNCs).
  • Utilizing the targeting and anti-inflammatory properties of macrophage membranes.
  • Employing the ROS-scavenging and catalase-like activity of PtNCs for oxidative stress regulation.
  • Evaluating MM-PtNCs in a mouse model of ischemia/reperfusion-induced AKI.

Main Results:

  • Systemic injection of MM-PtNCs significantly reduced renal damage in a mouse AKI model.
  • MM-PtNCs effectively restored kidney function.
  • The nano-system demonstrated efficacy in preventing the progression of AKI to chronic kidney disease.

Conclusions:

  • MM-PtNCs represent a promising multi-faceted therapeutic strategy for AKI.
  • The biomimetic nano-system effectively targets renal inflammation and mitigates oxidative stress.
  • This approach offers potential for clinical translation in AKI treatment.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...